Tomas Kalinicik

115PUBLICATIONS
306CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (115)

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 03, 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

|Jul 29, 2026
Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.

|Jul 24, 2026
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|Jul 03, 2026
Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Pageof 20

Frequent Collaborators

44 joint publications

Anneke Van der Walt

37 joint publications

Izanne Roos

22 joint publications

Vilija Jokubaitis

20 joint publications

Michael H Barnett